MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-11-2026
Zhongchao Accounts Payables 2011-2026 | ZCMD
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Zhongchao
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 526 K | 535 K | 684 K | 141 K | 38.9 K | 408 K | 117 K | 23.6 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 684 K | 23.6 K | 309 K |
Quarterly Accounts Payables Zhongchao
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 38.9 K | - | 469 K | - | 408 K | - | - | - | 117 K | - | - | - | 23.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 469 K | 23.6 K | 211 K |
Accounts Payables of other stocks in the Health information services industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
7.39 M | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
330 M | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
10.1 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
442 M | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
104 M | - | - | $ 9.03 B | USA |
 |
iCAD
ICAD
|
1.11 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
57.2 M | $ 2.51 | -0.79 % | $ 235 M | USA |
 |
GoodRx Holdings
GDRX
|
14.1 M | $ 2.23 | 3.72 % | $ 860 M | USA |
 |
SCWorx Corp.
WORX
|
600 K | - | - | $ 7.71 M | USA |
 |
Akerna Corp.
KERN
|
1.96 M | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
16.8 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
6.94 M | - | -0.58 % | $ 51.7 M | USA |
 |
NextGen Healthcare
NXGN
|
11.4 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
18.7 M | - | - | $ 3.37 B | USA |
 |
10x Genomics
TXG
|
15.7 M | $ 24.8 | 5.17 % | $ 2.91 B | USA |
 |
OptimizeRx Corporation
OPRX
|
2.23 M | $ 6.05 | 2.02 % | $ 104 M | USA |
 |
Health Catalyst
HCAT
|
9.36 M | $ 1.12 | 5.66 % | $ 78.3 M | USA |
 |
HealthEquity
HQY
|
12.2 M | $ 81.36 | 1.81 % | $ 7.01 B | USA |
 |
Premier
PINC
|
19.6 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
11.5 M | $ 11.91 | 4.02 % | $ 875 M | USA |
 |
Phreesia
PHR
|
11.5 M | $ 8.6 | 0.47 % | $ 514 M | USA |
 |
R1 RCM
RCM
|
17.7 M | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
48 M | $ 5.24 | 0.38 % | $ 923 M | USA |
 |
Signify Health
SGFY
|
84.1 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
1.54 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
10.4 M | - | -46.64 % | $ 10.4 M | USA |
 |
American Well Corporation
AMWL
|
1.65 M | $ 5.51 | -0.72 % | $ 88.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
19.5 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
6.63 M | $ 20.34 | -0.15 % | $ 618 M | USA |
 |
Omnicell
OMCL
|
51.8 M | $ 36.33 | 3.77 % | $ 1.67 B | USA |
 |
Progyny
PGNY
|
95.1 M | $ 17.17 | 1.12 % | $ 1.47 B | USA |
 |
Veeva Systems
VEEV
|
37.6 M | $ 159.09 | 0.4 % | $ 26 B | USA |